T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Transmedics
TMDX
$3.11B
| $49.8M | 0.01% |
330,434
+33,110
| +11% | +$3.97M |
|
727
XPO
XPO
$24.7B
| $49.6M | 0.01% |
467,454
-266,910
| -36% | -$29.9M |
|
728
Pliant Therapeutics
PLRX
$66.9M
| $49.5M | 0.01% |
4,602,323
+643,235
| +16% | +$8.29M |
|
729
Bruker
BRKR
$8.83B
| $49.4M | 0.01% |
774,304
-287,320
| -27% | -$21.6M |
|
730
State Street
STT
$52.2B
| $49.4M | 0.01% |
667,622
+91,289
| +16% | +$6.8M |
|
731
Commault Systems
CVLT
$6.26B
| $49.2M | 0.01% |
404,314
+374,849
| +1,272% | +$40.3M |
|
|
APLS
732
DELISTED
Apellis Pharmaceuticals
APLS
| $49M | 0.01% |
1,276,426
-1,182,820
| -48% | -$53.6M |
|
733
Inspire Medical Systems
INSP
$1.68B
| $48.8M | 0.01% |
364,871
-94,895
| -21% | -$18M |
|
734
Hershey
HSY
$37.4B
| $48.7M | 0.01% |
264,644
-2,615
| -1% | -$506K |
|
735
Lincoln Electric
LECO
$15.5B
| $48.2M | 0.01% |
255,601
-10,497
| -4% | -$2.28M |
|
|
XYZ
736
Block Inc
XYZ
$49.9B
| $48.1M | 0.01% |
746,357
+48,834
| +7% | +$3.42M |
|
737
Geron
GERN
$982M
| $47.8M | 0.01% |
11,277,923
+9,212,960
| +446% | +$35.9M |
|
738
Atkore
ATKR
$3.17B
| $47.6M | 0.01% |
352,738
-96,585
| -21% | -$15.4M |
|
|
ENV
739
DELISTED
ENVESTNET, INC.
ENV
| $47.2M | 0.01% |
754,698
+599,855
| +387% | +$37.7M |
|
740
Cleveland-Cliffs
CLF
$6.93B
| $47.2M | 0.01% |
3,068,557
+184,308
| +6% | +$3.3M |
|
741
DuPont de Nemours
DD
$19.5B
| $47.2M | 0.01% |
466,691
-1,155
| -0.2% | -$113K |
|
742
Consolidated Edison
ED
$40.1B
| $47.1M | 0.01% |
526,850
+16,312
| +3% | +$1.51M |
|
743
Boyd Gaming
BYD
$6.05B
| $46.8M | 0.01% |
850,179
-152,259
| -15% | -$8.69M |
|
744
Kinross Gold
KGC
$31.9B
| $46.8M | 0.01% |
5,629,833
+880,353
| +19% | +$6.37M |
|
745
Builders FirstSource
BLDR
$7.91B
| $46.7M | 0.01% |
337,733
-147,174
| -30% | -$25M |
|
746
Kroger
KR
$35.1B
| $46.5M | 0.01% |
931,844
+25,696
| +3% | +$1.38M |
|
747
H&R Block
HRB
$6.76B
| $46.1M | 0.01% |
849,661
+269,434
| +46% | +$13.4M |
|
748
Stride
LRN
$3.48B
| $45.7M | 0.01% |
647,582
+139,138
| +27% | +$9.28M |
|
749
Galicia Financial Group
GGAL
$7.23B
| $45.5M | 0.01% |
+1,488,668
| New | +$47.8M |
|
750
Marvell Technology
MRVL
$199B
| $45.2M | 0.01% |
646,504
-28,510
| -4% | -$2M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.